121 related articles for article (PubMed ID: 4132173)
21. [The methods and results of treating early vocal cord carcinomas].
Seiferth LB; Kleinsasser O; Glanz H
Z Laryngol Rhinol Otol; 1973 Jun; 52(6):421-35. PubMed ID: 4734042
[No Abstract] [Full Text] [Related]
22. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.
Sun DI; Cho KJ; Cho JH; Joo YH; Jung CK; Kim MS
Clin Otolaryngol; 2009 Apr; 34(2):132-9. PubMed ID: 19413611
[TBL] [Abstract][Full Text] [Related]
23. Supraglottic anatomy the pre- or the peri-epiglottic space?
Maguire A; Dayal VS
Can J Otolaryngol; 1974; 3(4):432-45. PubMed ID: 4429872
[No Abstract] [Full Text] [Related]
24. Endoscopic treatment for early glottic cancer: indications and oncologic outcome.
Peretti G; Piazza C; Bolzoni A
Otolaryngol Clin North Am; 2006 Feb; 39(1):173-89. PubMed ID: 16469662
[No Abstract] [Full Text] [Related]
25. One hundred laryngeal cancers studies by serial section.
Kirchner JA
Ann Otol Rhinol Laryngol; 1969 Aug; 78(4):689-709. PubMed ID: 5799397
[No Abstract] [Full Text] [Related]
26. [Horizontal partial surgery of the larynx. Technic and results].
Mounier-Kuhn P; Gaillard J; Haguenauer JP; Gregoire D
Acta Otorhinolaryngol Belg; 1973; 27(7):960-5. PubMed ID: 4774332
[No Abstract] [Full Text] [Related]
27. [Modalities of tumor extension in epitheliomas of the larynx: therapeutic deductions].
Cachin Y; Gerard-Marchant R; Micheau C
Probl Actuels Otorhinolaryngol; 1973; ():163-83. PubMed ID: 4806403
[No Abstract] [Full Text] [Related]
28. [Treatment by conservative methods of endolaryngeal epitheliomas by radiotherapy and surgery as needed].
Dancot H; Blavier A; Hulet P; Feremans W
Bull Cancer; 1969; 56(4):449-66. PubMed ID: 5403289
[No Abstract] [Full Text] [Related]
29. A hystopathological study of thyroarytenoid muscle invasion in early (T1) glottic carcinoma.
Kocatürk S; Han U; Yilmazer D; Onal B; Erkam U
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):581-3. PubMed ID: 15806049
[TBL] [Abstract][Full Text] [Related]
30. Partial laryngectomy for irradiation failure.
Norris CM; Peale AR
Arch Otolaryngol; 1966 Nov; 84(5):558-62. PubMed ID: 5955284
[No Abstract] [Full Text] [Related]
31. Recurrences after endoscopic management of early (T1) glottic carcinoma.
Thomas JV; Olsen KD; Neel HB; DeSanto LW; Suman VJ
Laryngoscope; 1994 Sep; 104(9):1099-104. PubMed ID: 8072356
[TBL] [Abstract][Full Text] [Related]
32. Recurrent laryngeal cancer after surgical treatment.
Ratanaanekchai T; Reechaipichitkul W
J Med Assoc Thai; 2006 Mar; 89(3):350-3. PubMed ID: 16696419
[TBL] [Abstract][Full Text] [Related]
33. Predictors of thyroid gland invasion in glottic squamous cell carcinoma.
Sparano A; Chernock R; Laccourreye O; Weinstein G; Feldman M
Laryngoscope; 2005 Jul; 115(7):1247-50. PubMed ID: 15995515
[TBL] [Abstract][Full Text] [Related]
34. Surgical management of irradiation failures of nonfixed cancers of the glottic region.
Ballantyne AJ; Fletcher GH
Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):164-8. PubMed ID: 4810292
[No Abstract] [Full Text] [Related]
35. [Chemotherapy of cancers of the larynx and hypopharynx].
Leroux-Robert J
Acta Otorhinolaryngol Belg; 1973; 27(7):883-96. PubMed ID: 4129940
[No Abstract] [Full Text] [Related]
36. Endolaryngeal microsurgery in vocal cord carcinomas. Indications and results.
Kleinsasser O; Glanz H; Albanese S
Otolaryngol Pol; 1990; 44(3):170-1. PubMed ID: 2255538
[No Abstract] [Full Text] [Related]
37. [Results of surgical treatment of cancers of the endolarynx].
Piquet JJ; Desaulty A; Pilliaert JM; Decroix G
Acta Otorhinolaryngol Belg; 1973; 27(7):916-23. PubMed ID: 4774327
[No Abstract] [Full Text] [Related]
38. Incidence of nodal metastases in T2 supraglottic carcinoma.
Cummings CW
Arch Otolaryngol; 1974 Apr; 99(4):268-9. PubMed ID: 4817884
[No Abstract] [Full Text] [Related]
39. Adenosquamous carcinoma of the larynx.
Fujino K; Ito J; Kanaji M; Shiomi Y; Saiga T
Am J Otolaryngol; 1995; 16(2):115-8. PubMed ID: 7793505
[No Abstract] [Full Text] [Related]
40. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
